☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Biosimilars
Insights+ Key Biosimilars Events of March 2024
April 3, 2024
Insights+ Key Biosimilars Events of January 2024
February 8, 2024
Insights+ Key Biosimilars Events of September 2023
October 5, 2023
13th Summit on Biosimilars & Innovator Biologics
May 23, 2022
Biocad Presents Results of BCD-021 (biosimilar, bevacizumab) in P-III Study for the Treatment of NSCLC at ESMO 2021
October 27, 2021
Boehringer Ingelheim's Cyltezo (biosimilar- adalimumab) Receives the US FDA's sBLA Approval as the 1st Interchangeable Biosimilar...
October 18, 2021
Load more...
Back to Home